Work

FOLFOXIRI versus doublet-regimens in the first-line therapy of MSI-S right-sided (RS) metastatic colorectal cancer (mCRC): A survival analysis.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e15060

Authors: Alexandre A Jacome, Bryan K. Kee, David R. Fogelman, Imad Shureiqi, Arvind Dasari, Kanwal Pratap Singh Raghav, Van K. Morris, Benny Johnson, Robert A. Wolff, Michael J. Overman, Scott Kopetz, Jane Rogers, Shahab U. Ahmed, Amir Mehdizadeh, Cathy Eng

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947371709

Cites:

Cited by:

Related to: 10